Skip to main navigation
MENU
About Us
Pipeline
Science
Business Development
Investors & Media
Careers
Contact Us
Main Menu
About Us
Pipeline
Pipeline Home
Rilonacept
Mavrilimumab
KPL-716
Science
Business Development
Investors & Media
Investors & Media Home
News & Events
Press Releases
Events & Presentations
Articles
Stock Information
Stock Quote & Chart
Historical Price Lookup
Financial Information
SEC Filings
Annual Report & Proxy Statement
Tax Information
Corporate Governance
Documents & Charters
Board of Directors
Management
Committee Composition
Investor Resources
Investor FAQs
Investor Contacts
Email Alerts
Careers
Contact Us
INVESTORS & MEDIA
News & Events
Press Releases
Events and Presentations
Articles
Stock Information
Stock Quote & Chart
Historical Price Lookup
Financial Information
SEC Filings
Annual Report & Proxy Statement
Tax Information
Corporate Governance
Documents & Charters
Board of Directors
Management
Committee Composition
Investor Resources
Investor FAQs
Investor Contacts
Email Alerts
Investors &
Media
Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
November 16, 2019
Supporting Materials
View Presentation
1.4 MB
Print Page
RSS
Email Alerts
Search
